FOXO Technologies, Inc. (DWIN) | Stock price, performance, AI analysis | Thematic | AI powered fundamental research and development platform

Loading...

Research a topic Stock screener Find companies

Search for securities Load an existing portfolio Backtest

How to use About us Blog

|

|

Research a topic Stock screener Find companies

Search for securities Load an existing portfolio Backtest

How to use About us Blog

Follow our journey and product updates

Product

Research a topic Stock screener Find companies Search for securities Load an existing portfolio Backtest

Learn

Thematic overview Develop asset-backed products Company evaluations Backtesting and benchmarking Thematic branded indices Build investment strategies with crypto

Company

How to use About us Blog

Team Research

There is currently no saved research for this page.

FOXO Technologies, Inc. (DWIN)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation

Company performance

Add to research

Current Price

as of Jun 11, 2025

$0.30

P/E Ratio

N/A

Market Cap

$3.22M

Description

Add to research

FOXO Technologies, Inc. develops genetic sequencing technology, artificial intelligence and bioinformatics tools. It operates through the FOXO Labs and FOXO Life segments. The FOXO Labs segment is involved in research and development and is commercializing proprietary epigenetic biomarker technology. The FOXO Life segment is involved in combining life insurance with a dynamic molecular health and wellness platform. The company was founded on April 27, 2020 and is headquartered in West Palm Beach, FL.

Metrics

Add to research

Overview

HQWest Palm Beach, FL
SectorTechnology Services
IndustryPackaged Software
TickerDWIN
Price$0.303+1.00%

Trading Information

Market cap$3.22M
Float96.82%
Average Daily Volume (1m)2,445,773
Average Daily Volume (3m)7,853,180
EPS-$7.93

Company

Revenue$7.21M
Rev growth (1yr)39,918.93%
Net income-$0.62M
Gross marginN/A
EBITDA marginN/A
EBITDAN/A

EV$6.58M
EV/Revenue0.91
P/EN/A
P/S0.13
P/B0.11
Debt/Equity30.34

Documents

Add to research

SEC Filings

8-K (2025-06-04)

8-K (2025-05-20)

8-K (2025-05-06)

8-K (2025-04-29)

8-K (2025-04-28)

8-K (2025-04-17)

8-K (2025-04-04)

8-K (2025-03-19)

8-K (2025-03-18)

8-K (2025-03-12)

8-K (2025-03-05)

8-K (2025-02-24)

8-K (2025-01-28)

8-K (2025-01-27)

8-K (2025-01-17)

8-K (2025-01-16)

8-K (2025-01-07)

8-K (2025-01-02)

8-K (2024-12-31)

8-K (2024-12-27)

8-K (2024-12-23)

8-K (2024-12-17)

8-K (2024-12-16)

8-K (2024-12-11)

8-K (2024-12-10)

8-K (2024-12-04)

8-K (2024-12-02)

8-K (2024-11-29)

8-K (2024-11-25)

8-K (2024-11-18)

8-K (2024-10-25)

8-K (2024-10-23)

8-K (2024-10-18)

8-K (2024-10-15)

8-K (2024-09-12)

8-K (2024-08-14)

8-K (2024-08-08)

8-K (2024-07-31)

8-K (2024-07-23)

8-K (2024-07-16)

8-K (2024-06-26)

8-K (2024-06-18)

8-K (2024-06-14)

8-K (2024-06-13)

8-K (2024-06-04)

8-K (2024-06-03)

8-K (2024-05-09)

8-K (2024-04-23)

8-K (2024-02-16)

8-K (2024-02-07)

8-K (2024-01-25)

8-K (2024-01-19)

8-K (2024-01-05)

8-K (2023-12-19)

8-K (2023-11-27)

8-K (2023-11-13)

8-K (2023-11-02)

8-K (2023-10-16)

8-K (2023-10-05)

8-K (2023-09-19)

8-K (2023-09-07)

8-K (2023-08-31)

8-K (2023-08-23)

8-K (2023-08-18)

8-K (2023-08-10)

8-K (2023-08-08)

8-K (2023-07-21)

8-K (2023-07-20)

8-K (2023-06-22)

8-K (2023-06-16)

8-K (2023-06-15)

8-K (2023-05-30)

8-K (2023-05-17)

8-K (2023-05-11)

8-K (2023-04-18)

8-K (2023-03-31)

8-K (2023-03-20)

8-K (2023-03-10)

8-K (2023-02-08)

8-K (2023-02-03)

8-K (2023-02-02)

8-K (2023-01-12)

10-Q (2025-05-20)

10-Q (2024-11-19)

10-Q (2024-08-19)

10-Q (2024-06-28)

10-Q (2024-01-19)

10-Q (2023-08-10)

10-Q (2023-05-11)

10-K (2025-04-15)

10-K (2024-06-06)

10-K (2023-03-31)

Factset Street Account

FOXO Technologies unveils plans for new direct-to consumer offering combining the company's epigenetic data with the power of AI ($0.09, 0.00) (2023-10-30T17:17:14Z)

FOXO Technologies receives issue notification from USPTO for a patent leveraging machine learning approaches to enable the Commercialization of Epigenetic Biomarkers ($0.11, 0.00) (2023-10-13T12:06:06Z)

FOXO Technologies enters agreement to use KR8 AI's Eco System and iOS/Android app - 8-K ($0.06, 0.00) (2023-11-02T21:31:54Z)

FOXO Technologies completes strategic alternatives review and outlines latest progress executing corporate strategy ($0.10, 0.00) (2023-10-23T12:12:26Z)

FOXO Technologies announces 1-for-10 reverse stock split ($0.09, 0.00) (2023-10-27T21:16:12Z)

Ask a question

New feature

Thematic Research

View all of your research in one place. Toggle open the floating actions menu and click Open research sidebar to view your saved research for the current page.